Trial Profile
Comparison of late catch-up phenomenon after second generation DES implantation with Nobori, Promus Element, Resolute Integrity, Xience stents and with bare metal stent implantation in patients who underwent follow-up coronary angiography
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Sep 2017
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Umirolimus (Primary) ; Zotarolimus (Primary)
- Indications Coronary artery restenosis
- Focus Therapeutic Use
- 30 Sep 2017 New trial record
- 30 Aug 2017 Results presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology